Lung Cancer | Tumor

CURE’s lung cancer page is an extensive resource of cancer information featuring the latest lung cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on lung cancer.

FDA to Review Libtayo for Frontline Advanced NSCLC

January 19th 2022

After promising phase 3 clinical trial results, the FDA will consider Libtayo for approval to treat patients with advanced non-small cell lung cancer, regardless of PD-L1 status.

Can a Blood Test Detect Lung Cancer in High-Risk Adults?

January 19th 2022

A new study to evaluate the accuracy of a blood test for detecting lung cancer in high-risk adults has enrolled its first participant with plans to enroll thousands more.

Early Non-Small Cell Lung Cancer: Chemotherapy and Toxicity

January 17th 2022

Martin Dietrich, MD, PhD, describes the toxicity profiles of chemotherapy agents used in the adjuvant setting in early non-small cell lung cancer.

Early Non-Small Cell Lung Cancer and Adjuvant Therapy

January 17th 2022

Two experts detail the use of adjuvant therapy, including chemotherapy, in treating early non-small cell lung cancer.

Know the Risks and Benefits of Robotic Navigational Bronchoscopy for Lung Cancer

January 15th 2022

While robotic navigational bronchoscopy is an exciting advancement in diagnosing and staging lung cancer, the procedure does come with some risks and factors to consider, explained one expert.

Keytruda Has Favorable Results in Adjuvant NSCLC Treatment, a First in Stage 1b-3a

January 11th 2022

In an interim analysis from a phase 3 trial of Keytruda, the use of the immunotherapy drug was associated with significantly improved disease-free survival in patients with non-small cell lung cancer.

Molecular Testing for Early Non-Small Cell Lung Cancer

January 11th 2022

Dr. Martin Dietrich explains the role of molecular testing in early non-small cell lung cancer.

An Overview of Early Non-Small Cell Lung Cancer

January 11th 2022

Martin Dietrich, MD, PhD, and Jessica Donington, MD, MSCR, provide an overview on early non-small cell lung cancer and the available treatment options.

Some Allergy Medications May Positively Influence Immunotherapy Responses in Cancer, But Is Only ‘A Tip of the Iceberg’

January 6th 2022

Certain allergy medications like Zyrtec and Claritin may be the key for more patients to tolerate immunotherapy for several cancer types.

Go2 Foundation Expert Explains Who Should Be Screened for Lung Cancer and Why

January 4th 2022

Angela Criswell, director of quality screening and program initiatives at GO2 Foundation for Lung Cancer, discusses early detection and screening for lung cancer.

Biomarker Testing Helps To ‘Identify the Typos in a Script’ Following a Lung Cancer Diagnosis

January 4th 2022

Daniel Saez, treatment and trials navigator at the GO2 Foundation for Lung Cancer, discusses biomarker testing and precision medicine in lung cancer.

Combatting an Isolating Disease: An Expert Offers Lung Cancer Resources for Patients, Caregivers

January 4th 2022

Susan Smedley, national manager of community fundraising and endurance events at GO2 Foundation for Lung Cancer, offers resources for patients with lung cancer and their loved ones, as well as ways to get involved in the community.

While QOL Preferences Can Be Different, Lung Cancer Resources Can Match Patient Needs

January 4th 2022

Susan Smedley, national manager of community fundraising and endurance events at GO2 Foundation for Lung Cancer, discusses quality of life in lung cancer, and ways patients can communicate preferences to their health care providers.

FDA Grants Speedy Review for Novel NSCLC Therapy

January 4th 2022

The Food and Drug Administration will offer guidance and expedited review to CLN-081, a novel drug that is promising for the treatment of EGFR exon 20-mutated non-small cell lung cancer.

A Deep Dedication to Improving Outcomes for Patients With Lung Cancer

January 3rd 2022

An oncologist from Fox Chase Cancer Center in Philadelphia explains the early career mentorship that inspired his successful lung cancer career.

Breaking the Stigma: Anyone Can Get Lung Cancer

January 2nd 2022

Not having known much about lung cancer, a woman describes her shock at receiving a diagnosis despite being a non-smoker.

Innovating the Future of Lung Cancer Care

January 1st 2022

A lung cancer doctor explains how he got lucky to fill in a role in the lung cancer space, and his career and passion took off from there.

The Lung Cancer Advocate Who Is a Friend to All

December 31st 2021

A woman who has worked with Upal Basu Roy in the lung cancer space for many years explains why he is a lung cancer hero to everyone he has worked with, due to his dedication and empathy.

Rock Star Lung Cancer Supporter and Advocate

December 30th 2021

A lung cancer survivor describes a passionate advocate who has changed the world of many patients.

My Wife’s Oncologist Is a Hero

December 29th 2021

A man writes about how his wife’s doctor saved her life after she was given three weeks to three months to live.

Immunotherapy Use Increased in Patients Ineligible for Cancer Trials, Highlighting the Need for More Research in Vulnerable Populations

December 28th 2021

The use of immunotherapy in patients with advanced cancers and decreased fitness levels or organ function increased from 2014 to 2019, although trials for this treatment typically exclude this population.

A Champion for Expanding Access to Lung Cancer Breakthroughs

December 28th 2021

A colleague describes Dr. Edward S. Kim’s devotion to improving lung cancer care and creating more inclusive clinical trial practices.

Top Celebrity Cancer-Related News of 2021

December 27th 2021

Many individuals were affected by cancer in the year 2021, including those in the spotlight. Here’s a roundup of the most-read cancer-related news impacting celebrities this year.

Lung Cancer Research Advocacy Driven by Heart

December 27th 2021

A woman writes about the unique lung cancer advocate who leads his endeavors with his heart for change.

When a Lung Cancer Diagnosis Brings About a New Mission

December 26th 2021

After receiving an advanced non-small cell lung cancer diagnosis, a competitive runner and cyclist began running toward a new goal: becoming a lung cancer advocate.

Lung Cancer Hero Implements ‘Tar Wars’ School Initiative Program

December 25th 2021

Ellen Petree worked with local health care leaders and community nurses to help reduce the number of children who went on to use tobacco, lowering their risk for lung cancer.

Advanced NSCLC Survival May Be Impacted by Depression and Anxiety, Highlighting the Need for Mental Health Care

December 20th 2021

As treatments for NSCLC improve survival, this benefit may be affected by depression and anxiety, which is common in patients with the disease and may require patients to advocate for cognitive behavioral therapy among other approaches.

Making Cancer Medicine More Compassionate

December 19th 2021

A man writes about his wife’s oncologist, Dr. Frederic J. Kaye, and describes how he went above and beyond to provide supportive care during her lung cancer journey.

5 Cancer Clinical Trials You May Have Missed

December 18th 2021

There are many cancer clinical trials that patients can enroll in across the United States. Here is a snapshot of some of the more recent ones.

A Physician-Scientist With a Huge Heart for Patients With Lung Cancer

December 18th 2021

A colleague describes Dr. Nagla Abdel Karim’s exemplary compassion for patients with lung cancer and how she works hard to increase representation in cancer clinical trials.

NEXT PAGE
PREVIOUS PAGE